Clinical trial
Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia…
NCT00245544 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00245544 |
|---|---|
| Title | Safety and Preliminary Efficacy of MK0759 in Postherpetic Neuralgia (PHN)(0759-004) |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover Study to Explore the Safety and Preliminary Efficacy of Oral MK0759 in the Treatment of Postherpetic Neuralgia |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuralgia, Postherpetic |
| Intervention type | Drug |
| Interventions | MK0759 |
| Enrollment | 20 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Oct 28, 2005 |
| Last update posted | May 21, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: